{"organizations": [], "uuid": "7900a0b55a80f2d77d4575a36f8329959735fcb7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180411.html", "section_title": "Archive News &amp; Video for Wednesday, 11 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/health-meningitis/u-s-fights-bid-to-exclude-evidence-about-2012-meningitis-outbreak-idUSL1N1RO2H8", "country": "US", "domain_rank": 408, "title": "U.S. fights bid to exclude evidence about 2012 meningitis outbreak", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.013, "site_type": "news", "published": "2018-04-12T07:55:00.000+03:00", "replies_count": 0, "uuid": "7900a0b55a80f2d77d4575a36f8329959735fcb7"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/health-meningitis/u-s-fights-bid-to-exclude-evidence-about-2012-meningitis-outbreak-idUSL1N1RO2H8", "ord_in_thread": 0, "title": "U.S. fights bid to exclude evidence about 2012 meningitis outbreak", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "massachusetts", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "westlaw", "sentiment": "none"}, {"name": "new england compounding center", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Federal prosecutors are pushing back against an effort by a part-owner and eight former employees of Massachusetts pharmacy whose tainted drug caused a deadly 2012 meningitis outbreak to block evidence about the harm patients suffered from being introduced at trial.\nIn a brief filed on Tuesday in federal court in Boston, prosecutors said they plan to introduce evidence about mold-contaminated steroids produced by New England Compounding Center and the fungal meningitis outbreak that killed 76 people.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2EBxHAl\n ", "external_links": ["https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2EBxHAl", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://www.youtube.com/user/ReutersVideo", "https://instagram.com/reuters/"], "published": "2018-04-12T07:55:00.000+03:00", "crawled": "2018-04-12T14:13:43.001+03:00", "highlightTitle": ""}